VivoSim Lab, Inc. 宣布完成400万美元定向增发 依据纳斯达克规则以市价定价 获单一医疗健康领域机构投资者认购

美股速递
Jul 16

VivoSim Lab, Inc. 已宣布其定向增发定价,成功募集400万美元资金。此次发行严格依据纳斯达克规则,以市价定价,并成功获得一家专注于医疗健康领域的单一机构投资者全额认购。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10